These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24104691)

  • 1. The antimicrobial effects and metabolomic footprinting of carboxyl-capped bismuth nanoparticles against Helicobacter pylori.
    Nazari P; Dowlatabadi-Bazaz R; Mofid MR; Pourmand MR; Daryani NE; Faramarzi MA; Sepehrizadeh Z; Shahverdi AR
    Appl Biochem Biotechnol; 2014 Jan; 172(2):570-9. PubMed ID: 24104691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metalloantibiotics: synthesis, characterization and antimicrobial evaluation of bismuth-fluoroquinolone complexes against Helicobacter pylori.
    Shaikh AR; Giridhar R; Megraud F; Yadav MR
    Acta Pharm; 2009 Sep; 59(3):259-71. PubMed ID: 19819823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriostatic and bactericidal activity of ranitidine bismuth citrate in Helicobacter pylori clinical isolates.
    Alarcón T; Domingo D; Prieto N; López-Brea M
    Rev Esp Quimioter; 1999 Mar; 12(1):64-8. PubMed ID: 10209056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organobismuth compounds: activity against Helicobacter pylori.
    Dahlgren A; Gløgård C; Gammelsaether M; Aasen AJ; Klaveness J; Berdal BP; Bergan T
    Scand J Gastroenterol; 1999 Feb; 34(2):135-7. PubMed ID: 10192189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and structural characterisation of bismuth(III) hydroxamates and their activity against Helicobacter pylori.
    Pathak A; Blair VL; Ferrero RL; Junk PC; Tabor RF; Andrews PC
    Dalton Trans; 2015 Oct; 44(38):16903-13. PubMed ID: 26352159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural influences on the activity of bismuth(III) indole-carboxylato complexes towards Helicobacter pylori and Leishmania.
    Pathak A; Blair VL; Ferrero RL; Kedzierski L; Andrews PC
    J Inorg Biochem; 2017 Dec; 177():266-275. PubMed ID: 28583712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro antimicrobial susceptibility of Helicobacter pylori strains: isolation of strains resistant to clarithromycin].
    González C; García A; Daroch F; Kawaguchi F; Solar H; Rivera N; Vega E
    Rev Med Chil; 2001 Jun; 129(6):643-6. PubMed ID: 11510204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, characterization, and anti-Helicobacter pylori activity of Bi3+-Hericium erinaceus polysaccharide complex.
    Zhu Y; Chen Y; Li Q; Zhao T; Zhang M; Feng W; Takase M; Wu X; Zhou Z; Yang L; Wu X
    Carbohydr Polym; 2014 Sep; 110():231-7. PubMed ID: 24906751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bismuth(III) complexes derived from α-amino acids: the impact of hydrolysis and oxido-cluster formation on their activity against Helicobacter pylori.
    Busse M; Border E; Junk PC; Ferrero RL; Andrews PC
    Dalton Trans; 2014 Dec; 43(48):17980-90. PubMed ID: 25310996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The action of bismuth against Helicobacter pylori mimics but is not caused by intracellular iron deprivation.
    Bland MV; Ismail S; Heinemann JA; Keenan JI
    Antimicrob Agents Chemother; 2004 Jun; 48(6):1983-8. PubMed ID: 15155188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional disruption of HypB, a GTPase of Helicobacter pylori, by bismuth.
    Xia W; Li H; Sun H
    Chem Commun (Camb); 2014 Feb; 50(13):1611-4. PubMed ID: 24389922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remarkable in vitro bactericidal activity of bismuth(III) sulfonates against Helicobacter pylori.
    Andrews PC; Busse M; Deacon GB; Ferrero RL; Junk PC; MacLellan JG; Vom A
    Dalton Trans; 2012 Oct; 41(38):11798-806. PubMed ID: 22903621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bismuth(III) β-thioxoketonates as antibiotics against Helicobacter pylori and as anti-leishmanial agents.
    Andrews PC; Blair VL; Ferrero RL; Junk PC; Kedzierski L; Peiris RM
    Dalton Trans; 2014 Jan; 43(3):1279-91. PubMed ID: 24190067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and characterisation of bismuth(III) aminoarenesulfonate complexes and their powerful bactericidal activity against Helicobacter pylori.
    Busse M; Trinh I; Junk PC; Ferrero RL; Andrews PC
    Chemistry; 2013 Apr; 19(17):5264-75. PubMed ID: 23536213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bismuth(III) benzohydroxamates: powerful anti-bacterial activity against Helicobacter pylori and hydrolysis to a unique Bi34 oxido-cluster [Bi34O22(BHA)22(H-BHA)14(DMSO)6].
    Pathak A; Blair VL; Ferrero RL; Mehring M; Andrews PC
    Chem Commun (Camb); 2014 Dec; 50(96):15232-4. PubMed ID: 25341969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial activity of Tabebuia impetiginosa Martius ex DC (Taheebo) against Helicobacter pylori.
    Park BS; Lee HK; Lee SE; Piao XL; Takeoka GR; Wong RY; Ahn YJ; Kim JH
    J Ethnopharmacol; 2006 Apr; 105(1-2):255-62. PubMed ID: 16359837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and activity of some novel organo-metallic complexes against Helicobacter pylori.
    Nagarajan R; Mehta SI; Naik SR; Fabry W
    Arzneimittelforschung; 1999 Nov; 49(11):951-4. PubMed ID: 10604049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the antimicrobial effects of several isothiocyanates on Helicobacter pylori.
    Haristoy X; Fahey JW; Scholtus I; Lozniewski A
    Planta Med; 2005 Apr; 71(4):326-30. PubMed ID: 15856408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication.
    Sun Q; Liang X; Zheng Q; Liu W; Xiao S; Gu W; Lu H
    Helicobacter; 2010 Jun; 15(3):233-8. PubMed ID: 20557366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Making bispirin: synthesis, structure and activity against Helicobacter pylori of bismuth(III) acetylsalicylate.
    Andrews PC; Blair VL; Ferrero RL; Junk PC; Kumar I
    Chem Commun (Camb); 2013 Apr; 49(28):2870-2. PubMed ID: 23450139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.